Financials in USD. Standardized financial statements.
A compact view of how Cardiovascular Systems, Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $236.22M | $258.97M | $236.54M | $248.02M | $217.04M | $204.91M | $178.18M | $181.54M | $136.61M | $103.90M |
| Revenue Growth? | -8.8% | +9.5% | -4.6% | +14.3% | +5.9% | +15.0% | -1.9% | +32.9% | +31.5% | 0.0% |
| Cost of Revenue? | $63.44M | $61.13M | $48.76M | $47.68M | $39.48M | $39.44M | $35.42M | $39.52M | $31.04M | $24.38M |
| Gross Profit? | $172.78M | $197.84M | $187.79M | $200.34M | $177.56M | $165.47M | $142.76M | $142.02M | $105.57M | $79.52M |
| Gross Margin? | +73.1% | +76.4% | +79.4% | +80.8% | +81.8% | +80.8% | +80.1% | +78.2% | +77.3% | +76.5% |
| Operating Expenses? | $208.59M | $209.78M | $214.56M | $201.16M | $175.32M | $167.01M | $188.48M | $174.66M | $139.06M | $101.93M |
| Operating Income? | -$35.81M | -$11.93M | -$26.77M | -$825,000 | -$1.70M | -$1.54M | -$56.08M | -$32.64M | -$33.49M | -$22.42M |
| EBITDA? | -$33.65M | -$10.22M | -$23.80M | $5.07M | $2.23M | -$1.54M | -$35.35M | -$32.64M | -$33.49M | -$22.42M |
| Income Before Tax | -$36.62M | -$13.17M | -$27.00M | -$65,000 | $1.84M | -$1.71M | -$56.02M | -$32.82M | -$35.29M | -$24.04M |
| Income Tax Expense | $310,000 | $252,000 | $231,000 | $190,000 | $132,000 | $86,000 | $0 | $0 | -$333,000 | $0 |
| Net Income? | -$36.93M | -$13.42M | -$27.24M | -$255,000 | $1.71M | -$1.79M | -$56.02M | -$32.82M | -$35.29M | -$24.04M |
| EPS? | $-0.94 | $-0.35 | $-0.79 | $-0.01 | $0.05 | $-0.06 | $-1.72 | $-1.04 | $-1.25 | $-1.11 |
| Diluted EPS? | $-0.94 | $-0.35 | $-0.79 | $-0.01 | $0.05 | $-0.06 | $-1.72 | $-1.04 | $-1.25 | $-1.11 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality